[1] Culver E L,Chapman R W. IgG4-related hepatobiliary disease: an overview[J].Nat Rev Gastroenterol Hepatol, 2016, 13(10): 601-612.
[2] Kamisawa T,Okazaki K. Diagnosis and treatment of IgG4-related disease[J].Curr Top Microbiol Immunol, 2017, 401: 19-33.
[3] Carruthers M N, Khosroshahi A, Augustin T, et al. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease[J]. Ann Rheum Dis, 2015, 74(1): 14-18.
[4] Kamisawa T,Funata N,Hayashi Y, et al. A new clinicopathological entity of IgG4-relatedautoimmune disease[J].Journal of gastroenterology,2003,38(10):982-984.
[5] 张勇,张学明,张伟辉. CA199在良恶性梗阻性黄疸鉴别应用中的研究进展[J].医学综述,2017,23(6):1080-1084.
[6] 中国抗癌协会肝癌专业委员会胆管癌协作组. 原发性肝癌诊疗指南之肝内胆管癌诊疗中国专家共识(2022版)[J].中华消化外科杂志,2022,21(10):1269-1301.
[7] 张怡安,沈锡中,刘韬韬.IgG4相关肝脏炎性假瘤合并肝癌[J].中华消化杂志,2013,33(4):281-282.
[8] 魏彬,欧晓琪,郭英,等.IgG4相关性肾病合并横结肠癌一例[J].中华肾脏病杂志,2020,36(10):778-780.
[9] Liu Y Y,Fu J N,Ning X R, et al. Malignancy risk of immunoglobin G4-related disease: evidence from a large cohort multicenter retrospective study[J].Rheumatol Ther, 2021, 8(3): 1207-1221.
[10] Yu T F,Wu Y X,Liu J, et al. The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis[J].Arthritis Res Ther, 2022, 24(1): 14.
[11] 袁轶群,张锐.免疫球蛋白G4相关性疾病与恶性肿瘤[J].中华临床免疫和变态反应杂志,2017,11(3):285-290.
[12] 姜丹丹,张跃,赵兴亮,等.免疫球蛋白G4相关性疾病与恶性肿瘤的鉴别和相关性[J].中华消化杂志,2020,40(10):712-715. |
